Skip to main content
  • Home
  •  Available Courses

Most Recent Courses

Getting it Right First Time in Severe Aortic Stenosis - Key Insights for Long Term Success
  • 1.00 EBAC

Learning objectives

  • Recall current and predicted trends in TAVI with respect to preserving coronary access
  • Consider determining factors for choosing valves in low risk populations
  • Discuss solutions for maximising valve durability and haemodynamics and for treating degenerated TAVI
See more
Implementing Heart Failure Guidelines with Collaborative Care
  • Not accredited

Learning objectives

  • Appraise new updates in heart failure guideline-directed medical therapy (GDMT)
  • Apply latest guideline recommendations to patient cases
  • Describe barriers preventing early initiation of GDMT
  • Identify the roles of nurses and other healthcare professionals to achieve optimal heart failure therapy
  • Identify the importance of the nurse/cross-functional team
See more
The Advancing Management of Transthyretin Amyloidosis
  • 1.00 EBAC

Learning objectives

  • To differentiate ATTR phenotypes based on presenting signs and symptoms.
  • To select appropriate tests to monitor symptomatic ATTR-cm from imaging, biomarker, functional and QoL assessments.
  • To recall how to identify disease progression across ATTR-cm.
  • To describe the different disease modifying treatments for ATTR including novel agents.
See more
An Expert Interpretation of the ESC Cardiomyopathy Guidelines 2023
  • 1.00 EBAC

Learning objectives

  • Recall guideline updates relevant to the use of disease modifying agents in hypertrophic cardiomyopathy
  • Identify patients who, according to guidelines, may benefit from emerging disease modifying therapies prior to septal ablation therapy or being managed by symptom control alone
  • Discuss long-term management strategies for patients receiving myosin inhibitor therapy
See more
Achieving Lipid Targets & Managing CV Risk: Reassessing our way with Statins
  • 1.00 EBAC

Learning objectives

  • Recall prevalence of patients who are statin uncontrolled/intolerant
  • Define the additive benefit of combination treatment compared with statin intensification
  • Name the non-statin LLTs offering proven CV protection
  • Identifying patients with indication for novel non-statin therapy
  • Initiate lipid-lowering strategies proven to lower future CV events
See more
The Clinical Evidence Behind Pulse Field Ablation
  • 1.00 EBAC

Learning objectives

  • Identify limitations of current ablation technologies
  • Recall the advantages of pulse field ablation over other technologies
  • Summarise the design, efficacy and safety findings of relevant clinical trial data evaluating the efficacy and safety of pulse field ablation technology
  • Compare different PFA systems and emerging technologies
  • Evaluate the evolving landscape of pulse field ablation technologies
See more
VIO 2022 - PAD/ LOWER LIMB - Part 2
  • 2.00 EBAC

Learning objectives

  • To develop an understanding of available treatment strategies for challenging and difficult access procedures
See more
VIO 2022 - PAD/ LOWER LIMB - Part 1
  • 2.00 EBAC

Learning objectives

  • To develop an understanding of available treatment strategies for challenging and difficult access procedures
  • To update knowledge on the latest technological developments and options
  • To gain insight into tips and tricks employed at leading international centres
See more
VIO 2022 - Venous - Part 2
  • 2.00 EBAC

Learning objectives

  • To develop an understanding of available treatment strategies for challenging and difficult access procedures
  • To update knowledge on the latest technological developments and options
  • To gain insight into tips and tricks employed at leading international centres
See more